510(k) Report

510(k) · Cleared

Cleared

Genie Cup Integrated Screening Device

K980836510(k) TraditionalCleared Jun 29, 1998117-day reviewClass II21 CFR 862.3870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Applied Technology Ventures, LLC · LDJ Enzyme Immunoassay, Cannabinoids

Cleared on Jun 29, 1998 after a 117-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Jun 29, 1998
Review
117 days
Class
Class II
Product code
LDJ
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K980836Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LDJ device

  1. #1 K232732 Rapid Marijuana (THC) Test Strip 20, Rapid…score 9.4 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LDJ devices

LDJ Enzyme Immunoassay, Cannabinoids: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LDJ

2in 2024

2008: 22009: 12011: 42012: 42013: 32014: 22015: 32016: 12019: 12023: 12024: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LDJ

48in 2015

2011: 219 days median2012: 193 days median2013: 162 days median2015: 48 days median
2007high 219 (2011) · low 48 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LDJ

1in 2023

2008: 42023: 1
2007high 4 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LDJ

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code LDJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—40
20091—00
20100—00
2011421900
2012419300
2013316200
20142—00
201534801
20161—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—10
20242—00
20250—00
20260—0—

What is it indicated for?

The Genie Cup™ Integrated Screening Device is a professional use, rapid, multiple immunoassay test for the qualitative determination of the major metabolites of the following drugs of abuse in human urine at the SAMHSA specified (except for methamphetamines) cutoff concentrations. amphetamines 1000 ng/ml cocaine 300 ng/ml opiates 300 ng/ml phencyclidine (PCP) 25 ng/ml cannabinoids (THC) 50 ng/ml methamphetamines 500 ng/ml Genie Cup™ Integrated Screening…

Read the full statement (120 words)

The Genie Cup™ Integrated Screening Device is a professional use, rapid, multiple immunoassay test for the qualitative determination of the major metabolites of the following drugs of abuse in human urine at the SAMHSA specified (except for methamphetamines) cutoff concentrations.

amphetamines 1000 ng/ml

cocaine 300 ng/ml

opiates 300 ng/ml

phencyclidine (PCP) 25 ng/ml

cannabinoids (THC) 50 ng/ml

methamphetamines 500 ng/ml

Genie Cup™ Integrated Screening Device provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgement should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K980836: Genie Cup Integrated Screening Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K980836

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026